2,145 Shares in Colgate-Palmolive (NYSE:CL) Acquired by apricus wealth LLC

apricus wealth LLC bought a new position in Colgate-Palmolive (NYSE:CL) in the first quarter, according to the company in its most recent disclosure with the SEC. The fund bought 2,145 shares of the company’s stock, valued at approximately $201,000.

A number of other large investors have also added to or reduced their stakes in the stock. Simon Quick Advisors LLC grew its position in Colgate-Palmolive by 57.2% in the 1st quarter. Simon Quick Advisors LLC now owns 11,117 shares of the company’s stock worth $1,042,000 after purchasing an additional 4,045 shares during the period. Zhang Financial LLC grew its position in shares of Colgate-Palmolive by 56.4% during the 1st quarter. Zhang Financial LLC now owns 15,695 shares of the company’s stock valued at $1,471,000 after acquiring an additional 5,660 shares during the period. Coerente Capital Management grew its position in shares of Colgate-Palmolive by 0.3% during the 1st quarter. Coerente Capital Management now owns 252,322 shares of the company’s stock valued at $23,643,000 after acquiring an additional 723 shares during the period. Trinity Financial Advisors LLC bought a new stake in shares of Colgate-Palmolive during the 1st quarter valued at $639,000. Finally, CX Institutional grew its position in shares of Colgate-Palmolive by 1,206.1% during the 1st quarter. CX Institutional now owns 59,286 shares of the company’s stock valued at $5,555,000 after acquiring an additional 54,747 shares during the period. Institutional investors own 80.41% of the company’s stock.

Colgate-Palmolive Stock Up 0.1%

Shares of CL stock opened at $92.02 on Thursday. The stock has a market cap of $74.57 billion, a P/E ratio of 26.14, a PEG ratio of 4.20 and a beta of 0.38. Colgate-Palmolive has a 52 week low of $85.32 and a 52 week high of $109.30. The company has a quick ratio of 0.58, a current ratio of 0.92 and a debt-to-equity ratio of 13.40. The company’s fifty day simple moving average is $91.64 and its two-hundred day simple moving average is $91.13.

Colgate-Palmolive (NYSE:CL) last announced its earnings results on Friday, April 25th. The company reported $0.91 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.86 by $0.05. The firm had revenue of $4.91 billion for the quarter, compared to analysts’ expectations of $4.92 billion. Colgate-Palmolive had a net margin of 14.38% and a return on equity of 477.77%. The business’s revenue was down 3.0% compared to the same quarter last year. During the same period in the prior year, the company earned $0.86 EPS. Analysts predict that Colgate-Palmolive will post 3.75 EPS for the current fiscal year.

Colgate-Palmolive Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Thursday, May 15th. Stockholders of record on Thursday, April 17th were given a dividend of $0.52 per share. This represents a $2.08 annualized dividend and a dividend yield of 2.26%. This is a boost from Colgate-Palmolive’s previous quarterly dividend of $0.50. The ex-dividend date was Thursday, April 17th. Colgate-Palmolive’s dividend payout ratio is currently 58.76%.

Colgate-Palmolive announced that its Board of Directors has initiated a stock repurchase plan on Thursday, March 20th that allows the company to buyback $5.00 billion in outstanding shares. This buyback authorization allows the company to repurchase up to 6.8% of its stock through open market purchases. Stock buyback plans are often a sign that the company’s management believes its shares are undervalued.

Wall Street Analyst Weigh In

CL has been the subject of a number of recent research reports. Barclays cut their price objective on shares of Colgate-Palmolive from $89.00 to $86.00 and set an “equal weight” rating for the company in a research report on Friday, April 11th. UBS Group boosted their price objective on shares of Colgate-Palmolive from $105.00 to $109.00 and gave the company a “buy” rating in a research report on Thursday, April 17th. Citigroup boosted their price objective on shares of Colgate-Palmolive from $103.00 to $108.00 and gave the company a “buy” rating in a research report on Monday, April 28th. Wells Fargo & Company boosted their price objective on shares of Colgate-Palmolive from $83.00 to $88.00 and gave the company an “underweight” rating in a research report on Wednesday, April 2nd. Finally, Wall Street Zen downgraded shares of Colgate-Palmolive from a “buy” rating to a “hold” rating in a report on Wednesday, May 7th. One equities research analyst has rated the stock with a sell rating, ten have given a hold rating and ten have given a buy rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Hold” and a consensus price target of $102.12.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.